UBS Group’s MoonLake Immunotherapeutics MLTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $605K | Buy |
|
|||||
|
2025
Q2 | $3.79M | Sell |
|
|||||
|
2025
Q1 | $4.72M | Buy |
|
|||||
|
2024
Q4 | $1.51M | Buy |
|
|||||
|
2024
Q3 | $320K | Buy |
|
|||||
|
2024
Q2 | $144K | Sell |
|
|||||
|
2024
Q1 | $741K | Buy |
|
|||||
|
2023
Q4 | $38.7K | Sell |
|
|||||
|
2023
Q3 | $64.1K | Buy |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $170K | Sell |
|
|||||
|
2022
Q4 | $771K | Sell |
|
|||||
|
2022
Q3 | $587K | Buy |
|
|||||
|
2022
Q2 | $387K | Buy |
|
|||||
|
2022
Q1 | $19K | Buy |
|
|||||
|
2021
Q3 | – | Sell |
|
|||||
|
2021
Q2 | $4K | Buy |
|